341 related articles for article (PubMed ID: 17584682)
1. Survival in cardiac resynchronization therapy. What do we know?
Préda I
Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():57-9. PubMed ID: 17584682
[TBL] [Abstract][Full Text] [Related]
2. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
[TBL] [Abstract][Full Text] [Related]
3. Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy?
Gupta SN; Jose VJ; Chandy ST
Indian Heart J; 2003; 55(6):619-23. PubMed ID: 14989512
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy: device-based medicine for heart failure.
Philippon F
J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
[TBL] [Abstract][Full Text] [Related]
6. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
[TBL] [Abstract][Full Text] [Related]
7. Twenty-millisecond interventricular difference as assessed by body surface potential mapping identifies patients with clinical improvement after implantation of cardiac resynchronization device.
Samesima N; Douglas R; Tobias N; Pedrosa A; Martinelli Filho M; Ramires JA; Pastore CA
Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():213-5. PubMed ID: 17584728
[TBL] [Abstract][Full Text] [Related]
8. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
9. Repercussions of cardiac resynchronization therapy on the ventricular repolarization of heart failure patients as assessed by body surface potential mapping.
Pastore CA; Douglas RA; Samesima N; Martinelli Filho M; Nishioka SD; Kaiser E; Ramires JA
Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():79-81. PubMed ID: 17584688
[TBL] [Abstract][Full Text] [Related]
10. Cardiac resynchronization therapy in heart failure patients: an update.
Jeevanantham V; Daubert JP; Zareba W
Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
[TBL] [Abstract][Full Text] [Related]
11. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
Aronow WS
Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy.
Abraham WT
Prog Cardiovasc Dis; 2006; 48(4):232-8. PubMed ID: 16517245
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
15. Biventricular pacing and cardiac resynchronization therapy: a fresh approach to heart failure and intraventricular conduction delay.
Mardell AP
Can J Cardiovasc Nurs; 2004; 14(1):29-38. PubMed ID: 15022530
[TBL] [Abstract][Full Text] [Related]
16. Cardiac resynchronization therapy in patients with minimally symptomatic heart failure.
Venkataraman G; Strickberger SA
Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):959-63. PubMed ID: 20602557
[TBL] [Abstract][Full Text] [Related]
17. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
18. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
[TBL] [Abstract][Full Text] [Related]
19. [Non-pharmacological therapy of decompensated heart failure: cardiac resynchronization therapy].
Storti C; Longobardi M; Buzzi MP; Negro MC; Pilun EB; Baldi A; Falcone C
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):123S-128S. PubMed ID: 19195320
[TBL] [Abstract][Full Text] [Related]
20. Effect of cardiac resynchronization therapy on ventricular remodeling.
Auricchio A; Spinelli JC; Trautmann SI; Kloss M
J Card Fail; 2002 Dec; 8(6 Suppl):S549-55. PubMed ID: 12555172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
